A Day Up For Neoleukin Therapeutics, Inc.

Neoleukin Therapeutics, Inc. (NLTX:NASDAQ) soared at $7.96, representing a gain of 26.8%. On Mon 09 Dec 19, NLTX:NASDAQ touched a New 2-Week High of $6.28. The stock got featured on our News Catalysts scanner on Thu 05 Dec 19 at 08:31 AM in the 'RECOMMENDATION' category. From Mon 18 Nov 19, the stock recorded 50.00% Up Days and 66.67% Green Days

About Neoleukin Therapeutics, Inc. (NLTX:NASDAQ)

Neoleukin Therapeutics Inc operates as a biopharmaceutical company. It generates immunotherapies using de novo protein design technology. The firm uses computational methods to design proteins that demonstrate specific pharmaceutical properties that provide potentially superior therapeutic benefit over native proteins to treat serious diseases, including cancer, inflammatory, and autoimmune disorders. Its product line comprises of NL-201, is a combined IL-2 and IL-15 agonist designed to eliminate alpha receptor binding.